Mr Rick L Paulson, MD | |
115 W Century Ave, Suite B, Bismark, ND 58803 | |
(701) 255-2252 | |
(701) 255-2255 |
Full Name | Mr Rick L Paulson |
---|---|
Gender | Male |
Speciality | Plastic Surgery |
Location | 115 W Century Ave, Bismark, North Dakota |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1790705168 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208200000X | Plastic Surgery | 7486 (North Dakota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Rick L Paulson, MD 115 W Century Ave, Suite B, Bismark, ND 58803 Ph: (701) 255-2252 | Mr Rick L Paulson, MD 115 W Century Ave, Suite B, Bismark, ND 58803 Ph: (701) 255-2252 |
News Archive
Finding a new doctor for health checkups and general care can pose a challenge to anyone. But for people who take prescription opioid pills for their chronic pain, it might be far harder, according to a new study.
In a finding with potentially major implications for identifying a viral cause of prostate cancer, researchers at the University of Utah and Columbia University medical schools have reported that a type of virus known to cause leukemia and sarcomas in animals has been found for the first time in malignant human prostate cancer cells.
Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the European Medicines Agency has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of pancreatic cancer.
The rates of regional brain loss and cognitive decline caused by aging and the early stages of Alzheimer's disease (AD) are higher for women and for people with a key genetic risk factor for AD, say researchers at the University of California, San Diego School of Medicine in a study published online July 4 in the American Journal of Neuroradiology.
The American Cancer Society and the Clinton Health Access Initiative (CHAI) today announced agreements with pharmaceutical companies Pfizer, Novartis, and Mylan to expand access to 20 lifesaving cancer treatments in 26 countries in sub-Saharan Africa and Asia. Purchasers are expected to save an average of 59 percent for medicines procured through the agreements.
› Verified 9 days ago